Pharmaniaga Berhad (KLSE: PHARMA)

Market Cap	533.25M
Revenue (ttm)	3.48B
Net Income (ttm)	-56.33M
Shares Out	1.44B
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	10.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	469,500
Open	0.380
Previous Close	0.380
Day's Range	0.370 - 0.380
52-Week Range	0.295 - 0.500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About Pharmaniaga Berhad

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products. The company also manufactures and sells generic drugs; ove...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1994
• Employees: 3,476
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: PHARMA

Financial Performance

In 2023, Pharmaniaga Berhad's revenue was 3.40 billion, a decrease of -2.20% compared to the previous year's 3.48 billion. Losses were -80.16 million, -87.27% less than in 2022.